Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works-Reference-Cited by-同舟云学术

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works

Published:2017-07-22 Issue:10 Volume:40 Page:855-869
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Santoro Aniello^ORCID,Genov Georgy,Spooner Almath,Raine June,Arlett Peter

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/article/10.1007/s40264-017-0572-8/fulltext.html

Reference57 articles.

1. World Health Organization. Pharmacovigilance. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/ (2017). Accessed 3 Jul 2017.

2. European Commission. MEMO/08/782, Brussels, 10 December November 2008. Strengthening pharmacovigilance to reduce adverse effects of medicines. http://europa.eu/rapid/press-release_MEMO-08-782_en.htm?locale=en (2017). Accessed 3 Jul 2017.

3. European Commission. Pharmacovigilance. http://ec.europa.eu/health/human-use/pharmacovigilance/index_en.htm (2017). Accessed 3 Jul 2017.

4. European Medicines Agency. Pharmacovigilance Risk Assessment Committee (PRAC). http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000537.jsp (2017). Accessed 3 Jul 2017.

5. European Medicines Agency. Good pharmacovigilance practices. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp (2017). Accessed 3 Jul 2017.

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures;Current Drug Safety;2024-11

2. Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action;Pharmacoepidemiology and Drug Safety;2024-08-30

3. The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System;Drug Safety;2024-07-10

4. The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance;Clinical Therapeutics;2024-07

5. Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review;Pharmaceuticals;2024-06-19